PubRank

Eiji Higashihara

Author PubWeight™ 41.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012 9.88
2 Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet 2002 1.43
3 Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis 2011 1.39
4 Initial operative experience of single-port retroperitoneal laparoscopic nephrectomy. Int J Urol 2012 1.39
5 Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol 2009 1.15
6 Amino acid transporter LAT3 is required for podocyte development and function. J Am Soc Nephrol 2009 1.06
7 Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int 2004 1.04
8 Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer. J Urol 2008 1.02
9 Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer. Int J Urol 2010 0.97
10 Laparoscopic management of urachal remnants in adulthood. Int J Urol 2006 0.96
11 Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. Lab Invest 2011 0.94
12 Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease. Nephron Clin Pract 2005 0.94
13 Prostatic cyst arising around the bladder neck-cause of bladder outlet obstruction: two case reports. Hinyokika Kiyo 2007 0.92
14 [Comparison of clinical results between TUR-P and holmium laser enucleation of the prostate (HoLEP) based on the initial experience]. Nihon Hinyokika Gakkai Zasshi 2008 0.91
15 Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy. Int J Urol 2006 0.91
16 Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster. Cancer Sci 2007 0.89
17 New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med 2005 0.88
18 Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis. Hum Cell 2008 0.88
19 Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer. Int J Urol 2010 0.87
20 A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells. J Urol 2007 0.86
21 Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience. Int J Urol 2010 0.85
22 Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients. Int J Urol 2004 0.84
23 Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. Hum Gene Ther 2007 0.84
24 Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus. Vaccine 2005 0.81
25 Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer. J Urol 2004 0.81
26 Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Int J Urol 2006 0.80
27 Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer. Int J Urol 2009 0.80
28 Predictors of septic shock in obstructive acute pyelonephritis. World J Urol 2013 0.79
29 Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome. Lab Invest 2008 0.79
30 Genotypes of autosomal dominant polycystic kidney disease in Japanese. J Hum Genet 2002 0.79
31 Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation. Cancer Immunol Immunother 2008 0.78
32 Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma. BMC Res Notes 2014 0.78
33 11beta-hydroxysteroid dehydrogenase type 2 is expressed in the human kidney glomerulus. J Clin Endocrinol Metab 2002 0.77
34 The effect of eicosapentaenoic acid on prostate-specific antigen. In Vivo 2006 0.77
35 Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor. J Urol 2005 0.76
36 [Predicting postoperative recurrence of renal cell carcinoma using serum vascular endothelial growth factor]. Nihon Hinyokika Gakkai Zasshi 2013 0.76
37 A pilot study of quality of life of patients with hormone-refractory prostate cancer after gene therapy. Anticancer Res 2009 0.75
38 [Case of congenital bladder diverticulum--cause of urinary retention in adulthood]. Nihon Hinyokika Gakkai Zasshi 2010 0.75
39 [Urological cancer]. Gan To Kagaku Ryoho 2005 0.75
40 Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL. Int J Urol 2003 0.75
41 [Polycystic kidney disease]. Nihon Jinzo Gakkai Shi 2007 0.75
42 Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor. Urology 2003 0.75
43 Retroperitoneal laparoscopic single-site nephroureterectomy: Initial operative experience. Asian J Endosc Surg 2012 0.75
44 [Prevalence and preference with regard to various surgical treatments for benign prostatic hypertrophy: a survey for the Japanese endourology and ESWL society member]. Nihon Hinyokika Gakkai Zasshi 2003 0.75
45 [Urolithiasis in hemodialysis patients]. Nihon Rinsho 2004 0.75
46 Comparison of transperitoneal and retroperitoneal laparoscopic nephrectomy for renal cell carcinoma: a single-center experience of 100 cases. Int J Urol 2008 0.75
47 Stimulation of virus-specific T cell responses by dendritic cell vaccination in the chronic phase of simian AIDS models. Jpn J Infect Dis 2004 0.75
48 [Urachal anomalies and tumor: clinical investigation of 14 cases]. Hinyokika Kiyo 2005 0.75
49 [A case of post-traumatic high flow priapism]. Nihon Hinyokika Gakkai Zasshi 2003 0.75